Cargando…

Rationale and design of a double-blind, placebo-controlled, randomized trial to evaluate the safety and efficacy of nimodipine in preventing cognitive impairment in ischemic cerebrovascular events (NICE)

BACKGROUND: Stroke is the second most common cause of mortality and the leading cause of neurological disability, cognitive impairment and dementia worldwide. Nimodipine is a dihydropyridinic calcium antagonist with a role in neuroprotection, making it a promising therapy for vascular cognitive impa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Penglian, Wang, Yongjun, Feng, Tao, Zhao, Xingquan, Zhou, Yong, Wang, Yilong, Shi, Weixiong, Ju, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488311/ https://www.ncbi.nlm.nih.gov/pubmed/22950711 http://dx.doi.org/10.1186/1471-2377-12-88

Ejemplares similares

Clopidogrel with aspirin in High-risk patients with Acute Non-disabling Cerebrovascular Events II (CHANCE-2): rationale and design of a multicentre randomised trial
por: Wang, Yongjun, et al.
Publicado: (2021)

China Antihypertensive Trial in Acute Ischemic Stroke II (CATIS-2): rationale and design
por: Liu, Liping, et al.
Publicado: (2021)

Tenecteplase Reperfusion therapy in Acute ischaemic Cerebrovascular Events-II (TRACE II): rationale and design
por: Li, Shuya, et al.
Publicado: (2021)

Shuxuetong for Prevention of recurrence in Acute Cerebrovascular events with Embolism (SPACE) trial: rationale and design
por: Gu, Hong-Qiu, et al.
Publicado: (2020)

Rationale and Study Design for a Single-Arm Phase IIa Study Investigating Feasibility of Preventing Ischemic Cerebrovascular Events in High-Risk Patients with Acute Non-disabling Ischemic Cerebrovascular Events Using Remote Ischemic Conditioning
por: Liu, Shi-Meng, et al.
Publicado: (2018)

Rationale and design of a randomised double-blind 2×2 factorial trial comparing the effect of a 3-month intensive statin and antiplatelet therapy for patients with acute mild ischaemic stroke or high-risk TIA with intracranial or extracranial atherosclerosis (INSPIRES)
por: Gao, Ying, et al.
Publicado: (2023)

Rationale and design of Patient-centered Retrospective Observation of Guideline-Recommended Execution for Stroke Sufferers in China: China PROGRESS
por: Li, Zixiao, et al.
Publicado: (2019)

Web-based tool for dynamic functional outcome after acute ischemic stroke and comparison with existing models
por: Ji, Ruijun, et al.
Publicado: (2014)

Nitrate Metabolism and Ischemic Cerebrovascular Disease: A Narrative Review
por: Wang, Yicong, et al.
Publicado: (2022)

Chinese Stroke Center Alliance: a national effort to improve healthcare quality for acute stroke and transient ischaemic attack: rationale, design and preliminary findings
por: Wang, Yongjun, et al.
Publicado: (2018)

Impairment of cognition and sleep after acute ischaemic stroke or transient ischaemic attack in Chinese patients: design, rationale and baseline patient characteristics of a nationwide multicentre prospective registry
por: Wang, Yongjun, et al.
Publicado: (2020)

In-hospital medical complications associated with stroke recurrence after initial ischemic stroke: A prospective cohort study from the China National Stroke Registry
por: Wang, Penglian, et al.
Publicado: (2016)

Rationale, design and methodology of a double-blind, randomized, placebo-controlled study of escitalopram in prevention of Depression in Acute Coronary Syndrome (DECARD)
por: Hansen, Baiba Hedegaard, et al.
Publicado: (2009)

Rationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trial
por: Tanaka, Atsushi, et al.
Publicado: (2017)

The Third China National Stroke Registry (CNSR-III) for patients with acute ischaemic stroke or transient ischaemic attack: design, rationale and baseline patient characteristics
por: Wang, Yongjun, et al.
Publicado: (2019)

Rationale and design of interleukin-1 blockade in recently decompensated heart failure (REDHART2): a randomized, double blind, placebo controlled, single center, phase 2 study
por: Van Tassell, Benjamin, et al.
Publicado: (2022)

The design, rationale, and baseline characteristics of a nationwide cohort registry in China: blood pressure and clinical outcome in TIA or ischemic stroke
por: Xu, Jie, et al.
Publicado: (2016)

Rationale and design of a stepped wedge cluster randomised trial to improve acute reperfusion treatment quality for stroke: IMPROVE stroke care in China
por: Li, Zixiao, et al.
Publicado: (2022)

Design and rationale for the randomised, double-blinded, placebo-controlled Liraglutide to Improve corONary haemodynamics during Exercise streSS (LIONESS) crossover study
por: Myat, Aung, et al.
Publicado: (2015)

PolyvasculaR Evaluation for Cognitive Impairment and vaScular Events (PRECISE)—a population-based prospective cohort study: rationale, design and baseline participant characteristics
por: Pan, Yuesong, et al.
Publicado: (2020)

Leukocyte subtypes and adverse clinical outcomes in patients with acute ischemic cerebrovascular events
por: Wang, Anxin, et al.
Publicado: (2021)

Preventing Ischemic Cerebrovascular Events in High-Risk Patients With Non-disabling Ischemic Cerebrovascular Events Using Remote Ischemic Conditioning: A Single-Arm Study
por: Liu, Shimeng, et al.
Publicado: (2021)

The Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor and Aspirin for Prevention of Stroke and Death (THALES) trial: Rationale and design
por: Johnston, S Claiborne, et al.
Publicado: (2019)

Probiotic prophylaxis in patients with predicted severe acute pancreatitis (PROPATRIA): design and rationale of a double-blind, placebo-controlled randomised multicenter trial [ISRCTN38327949]
por: Besselink, Marc GH, et al.
Publicado: (2004)

Placebo-Controlled, Double-Blind Study of Empagliflozin (EMPA) and Implantable Cardioverter-Defibrillator (EMPA-ICD) in Patients with Type 2 Diabetes (T2DM): Rationale and Design
por: Fujiki, Shinya, et al.
Publicado: (2020)

Microbial Interventions to Control and Reduce Blood Pressure in Australia (MICRoBIA): rationale and design of a double-blinded randomised cross-over placebo controlled trial
por: Rhys-Jones, Dakota, et al.
Publicado: (2021)

Opicapone as an Add-on to Levodopa in Patients with Parkinson’s Disease Without Motor Fluctuations: Rationale and Design of the Phase III, Double-Blind, Randomised, Placebo-Controlled EPSILON Trial
por: Ferreira, Joaquim J., et al.
Publicado: (2022)

Design and Rationale of a Randomized, Double-Blind, Placebo-Controlled, Phase 2/3 Study Evaluating Dociparstat in Acute Lung Injury Associated with Severe COVID-19
por: Lasky, Joseph A., et al.
Publicado: (2020)

Effectiveness of steroids versus placebo in preventing upper airway obstruction after extubation in critically ill children: rationale and design of a multicentric, double-blind, randomized study
por: Manrique, Gema, et al.
Publicado: (2020)

In-hospital complications affect short-term and long-term mortality in ICH: a prospective cohort study
por: Zhang, Yaqing, et al.
Publicado: (2020)

A novel risk score to predict 1-year functional outcome after intracerebral hemorrhage and comparison with existing scores
por: Ji, Ruijun, et al.
Publicado: (2013)

Preconditioning by Preceding Ischemic Cerebrovascular Events
por: Correia, Pamela N., et al.
Publicado: (2021)

Risk score to predict gastrointestinal bleeding after acute ischemic stroke
por: Ji, Ruijun, et al.
Publicado: (2014)

Rationale and design of the multicentric, double-blind, double-placebo, randomized trial APrepitant versus HYdroxyzine in association with cytoreductive treatments for patients with myeloproliferative neoplasia suffering from Persistent Aquagenic Pruritus. Trial acronym: APHYPAP
por: Le Gall-Ianotto, C., et al.
Publicado: (2021)

Design of a randomised, double-blind, crossover, placebo-controlled trial of effects of sildenafil on cerebrovascular function in small vessel disease: Oxford haemodynamic adaptation to reduce pulsatility trial (OxHARP)
por: Webb, Alastair, et al.
Publicado: (2021)

Clinical assessment of complementary treatment with Qishen Yiqi dripping pills on ischemic heart failure: study protocol for a randomized, double-blind, multicenter, placebo-controlled trial (CACT-IHF)
por: Hou, Ya Zhu, et al.
Publicado: (2013)

Evaluating the effects of Danhong injection in treatment of acute ischemic stroke: study protocol for a multicenter randomized controlled trial
por: Li, Bing, et al.
Publicado: (2015)

Efficacy and safety of berberine for dyslipidemia: study protocol for a randomized double-blind placebo-controlled trial
por: Zhao, Ying, et al.
Publicado: (2021)

Nimodipine augments cerebrovascular reactivity in aging but runs the risk of local perfusion reduction in acute cerebral ischemia
por: Kecskés, Szilvia, et al.
Publicado: (2023)

Atrial fibrillation is not uncommon among patients with ischemic stroke and transient ischemic stroke in China
por: Yang, Xiaomeng, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6c7ljm7p2j5l6gdfosi0nqcnsl